no image available Dickens & Co. "Breaking the Chains of Macular Damage: A Groundbreaking Therapy Shows Promise for Nonproliferative Macular Telangiectasia Type 2" "Revolutionary Oral Carbonic Anhydrase Inhibitors Offer New Hope for Patients Struggling with Macular Degeneration" Price: 25.00€